Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Schrodinger Inc
(NQ:
SDGR
)
20.61
-0.24 (-1.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Schrodinger Inc
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Via
Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Citigroup Maintains Buy Rating for Schrodinger: Here's What You Need To Know
January 31, 2023
Via
Benzinga
4 Analysts Have This to Say About Schrodinger
January 31, 2023
Via
Benzinga
3 AI Stocks to Buy for the Future of Automation
February 17, 2023
Increased appreciation for AI and the Street's reduced hostility to growth stocks make this a good time to find AI stocks to buy.
Via
InvestorPlace
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
February 04, 2023
Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a...
Via
Talk Markets
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
January 21, 2023
Mabwell Biosciences out-licensed global rights for a rare disease drug to Disc Medicine of Cambridge, MA in a $412.5 million agreement. Mabwell will receive $10 million upfront, $402.5 million in...
Via
Talk Markets
Why These 7 Healthcare Stocks Could Soar in 2023
January 02, 2023
These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.
Via
InvestorPlace
7 Drug Stocks That Will Soar in 2023
December 22, 2022
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years.
Via
InvestorPlace
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
During Monday's session, 49 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 28, 2022
Via
Benzinga
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
November 07, 2022
U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
On Monday, 79 companies reached new 52-week lows.
Via
Benzinga
3 Hypergrowth Stocks That Will Make You a Millionaire by 2027
November 04, 2022
These companies' great third-quarter results, along with their very promising technologies, are likely to turn them into hypergrowth stocks.
Via
InvestorPlace
7 Small-Cap Stock Picks to Beat the September Market Slump
September 15, 2022
With the macro environment not as dreary as the bears believe, investors should consider buying one or more of my small-cap stock picks.
Via
InvestorPlace
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Via
Benzinga
Cathie Wood Loads Up $4.6M In Bill Gates-Backed Healthcare Tech Company
August 19, 2022
Cathie Wood-led Ark Investment Management on Thursday bought 162,276 shares of Schrodinger Inc (NASDAQ: SDGR) through the Ark Genomic Revolution ETF (BATS: ARKG), trading d
Via
Benzinga
Gain Therapeutics: Reasons For Optimism
August 09, 2022
In biotechnology, potential rules. And in Gain's case, the potential to not just treat but functionally cure at least some forms of Parkinson's Disease is strong enough to weather early-stage...
Via
Talk Markets
3 Biotech Stocks to Buy on the Dip
July 21, 2022
Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip.
Via
InvestorPlace
The 7 Best Stocks to Buy on a Dip in July
July 14, 2022
With the stock market pricing in a recession that likely won't arrive anytime soon, these are some of the best stocks to buy on a dip.
Via
InvestorPlace
Schrödinger's Initial-Stage Cancer Study Gains FDA Clearance
June 28, 2022
Schrödinger Inc. (NASDAQ: SDGR) announced that the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate SGR-1505 in patients with...
Via
Benzinga
Bill Gates Stocks: 7 Top Picks From the Gates Foundation Portfolio
June 13, 2022
These Bill Gates stocks are great picks to buy now. BRK-B, CNI, DE, ECL, MSFT, SDGR, and WM can make excellent long-term investments.
Via
InvestorPlace
Recap: Schrodinger Q1 Earnings
May 04, 2022
Schrodinger (NASDAQ:SDGR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Schrodinger beat estimated earnings...
Via
Benzinga
AI Pharma Startup METiS Raises $150 Million. IPO In Sight?
April 12, 2022
Key takeaways: METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest two worth $150 million The company was...
Via
Benzinga
Schrödinger New Preclinical Data Supports Development Of Its Wee1 Inhibitor In Cancer Indications
April 12, 2022
Schrödinger Inc (NASDAQ: SDGR)
Via
Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
April 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.